Abbott has introduced a glucose sport biosensor for athletes based on its FreeStyle Libre continuous glucose monitoring technology, originally developed for diabetes patients.
The device, Libre Sense Glucose Sport Biosensor, continuously measures glucose to help athletes better understand the correlation between their glucose levels and performance.
Abbott is launching Libre Sense Glucose Sport Biosensor as a consumer over-the-counter product. The device, which secured CE Mark, offers glucose monitoring through a mobile app.
Athletes aged 16 years and older involved in sports including cycling, running and swimming, can use it to understand the efficacy of their nutrition choices on training and competition, noted the company.
Tracking and understanding glucose levels allow athletes to make necessary nutrition choice, avoiding fatigue from low glucose.
Abbott Diabetes Care senior vice-president Jared Watkin said: “FreeStyleLibre changed the way millions of people manage their diabetes to get and stay healthier, and now with Libre Sense we’re bringing that same proven technology to empower athletes to help them reach their athletic performance goals.”
“This is just the beginning – our breakthrough sensing technology has the potential to go beyond glucose and provide a lens into what’s happening in the human body that could provide meaningful insights into other conditions, treatments, and ultimately improve health.”
Athletes must wear the small round biosensor on the back of their upper arm to obtain real-time glucose readings from Libre Sense Glucose Sport Biosensor, worn for up to 14 days.
Abbott is initially launching the product in Austria, France, Germany, Ireland, Italy, Luxembourg, Switzerland and the UK. It will be available in the coming weeks through the official website of Atlanta-based sports technology company Supersapiens.